Navigation Links
Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective
Date:12/8/2009

NEW YORK, Dec. 8 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Cardiac Biomarkers - A Global Market Perspective

http://www.reportlinker.com/p0164258/Cardiac-Biomarkers---A-Global-Market-Perspective.html

Rising cases of cardiovascular diseases and ageing population have served as primary growth drivers for cardiac biomarkers market, a key sector in the clinical immunodiagnostics market. The global healthcare sector places utmost importance on fast and accurate identification of heart problems, in order to initiate timely and accurate treatment at the earliest. Cardiac biomarkers help in detecting the severity and existence of heart problems at the earliest. The Point-of-Care Testing (POCT) platform is more popular among the new breed of physicians who give prime importance on faster results and mobility; while experienced physicians rely more on Laboratory Testing platform that is perceived to be more accurate and provide detailed analysis.

These and other market data and trends are presented in "Cardiac Biomarkers: A Global Market Perspective" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

CARDIAC BIOMARKERS BMR-1058

CONTENTS

1. METHODOLOGY 1

Study Reliability and Reporting Limitations 1

Disclaimers 2

Quantitative Techniques & Reporting Level 3

2. INDUSTRY OVERVIEW 4

Cardiovascular Diseases: Leading Cause of Mortality Worldwide 4

Basic Topologies of Cardiovascular Diseases 5

Fast and Accurate Diagnosis - Reduce Unnecessary Healthcare Costs 5

Cardiac Biomarkers - Making Diagnosis Easier and Quicker 6

What is a Cardiac Marker: 6

Necessity of a Cardiac Marker Assay Test 6

Major Cardiac Markers and their Properties 7

Market Outlook 8

Market Trends 8

Strong Demand for Risk Assessment Markers 8

Intense Competition among Players in the Cardiac Diagnostics

Market 8

The Future of Cardiac Marker POCT Segment 8

Need for Early Detection Markers 9

Rapid Turnaround time: A Crucial Parameter for POC Testing Kits 9

3. COMPETITIVE ANALYSIS 10

Siemens Healthcare becomes the leader, after a series of

Acquisitions 10

Product Portfolio of Bayer and Dade Behring 11

4. CARDIAC MARKERS AND MYOCARDIAL INFARCTION 12

Chain Reaction After an Event of MI 12

Action Plan after an Event of MI 12

Protocol for Conducting AMI Markers Tests 13

Creatine Kinase - The Traditional Gold Standard, Loosing Sheen 13

Isomers 13

Kinetics 14

Purpose of Test and When to Order 14

Cardiac Troponin - Taking Over from CK-MB 14

Overview 14

Troponin Tissue-Specific Subtypes 14

Other Diseases 15

Uses of Troponin Tests 15

New Advanced High-sensitivity (Hs) Cardiac Troponin Tests 15

Myoglobin 16

Purpose of Test and When to Order 16

5. CARDIAC MARKERS AND CONGESTIVE HEART FAILURE (CHF) 16

Key Facts 17

BNP (B-type Natriuretic Peptide) 17

NT-proBNP (N-terminal proBNP) 18

Purpose of Tests and When to Order 18

Market Characteristics 18

Choosing the Right BNP and NT proBNP Assay Kit in the Market 20

Evolution of BNP and NT proBNP Market 20

NT-proBNP is superior to BNP in Predicting Mortality in Heart

Failure Patients, with Reduced Kidney Function 21

6. STROKE BIOMARKERS - A REVIEW 21

Player Initiatives 22

Other Important Cardiac Biomarkers 22

Homocysteine 22

C-Reactive Protein 23

Plasminogen Activator Inhibitor-1 24

D-Dimer 24

Thrombus Precursor Protein 24

Potential Future Cardiac Biomarkers 24

7. CARDIAC BIOMARKER TESTING IN CLINICAL LABORATORIES 27

Leading Players in Laboratory Cardiac Markers 27

8. CARDIAC BIOMARKERS AT POINT-OF- CARE TESTING 28

Major Players Operating in the Cardiac Markers POCT Segment 28

Cardiac Markers Point-of-Care testing (POCT) Segment: Major

Players & Their Operating Brands 29

9. CORPORATE DEVELOPMENTS 30

Response Biomedical Signs Partnership Agreement with Roche 30

Nanogen and Elitech Plans to Merge 30

Compugen Announces Discovery of Troponin I Biomarker Variant,

Inks Agreement with Biosite 30

Response Bags FDA Clearance for RAMP® NT-proBNP Test 31

Inverness Acquires Biosite 31

Siemens Acquires Diagnostic Division of Bayer Healthcare 31

Siemens Announces Acquisition of Dade Behring 31

Beckman Collaborates in CVD Related Research Projects 32

Dade Behring Receives Sublicense to New Cardiac Marker 32

Inverness Acquires Cholestech 32

Response Biomedical Secures Clearance to Market RAMP® NT-

proBNP Test 33

Acrongenomics Collaborates with Molecular Vision and Pearson

Matthews 33

BG Medicine Obtains Rights to Develop Tests for Congestive

Heart Failure 33

Nanogen Gains US Reissue Patent for Combined Use of Biomarkers

for CHF Diagnosis 34

bioMerieux Rolls out VIDAS® NT-proBNP 34

Roche Diagnostics Introduces Cobas-H-232 Handheld Cardiac

Marker System 34

XIS Discovers a Unique Diagnostic Biomarker for Cardiovascular

Disease 35

Ortho-Clinical Presents Sensitivity Troponin I Test, VITROS

Troponin I ES 35

10. MAJOR PLAYERS 36

Abbott Diagnostics (USA) 36

Ani Biotech Oy (Finland) 36

Axis-Shield PoC (UK) 36

Beckman Coulter, Inc. (USA) 36

biomerieux (France) 37

Inverness Medical Innovations, Inc. (USA) 37

LifeSign LLC (USA) 37

Nanogen Inc. (USA) 37

Ortho-Clinical Diagnostics, Inc. (USA) 37

Oxis International, Inc. (USA) 38

Prognostix, Inc. (USA) 38

Response Biomedical Corp. (Canada) 38

Roche Diagnostics Corp. (USA) 39

Siemens Healthcare Diagnostics, Inc. (USA) 39

11. GLOBAL MARKET ANALYTICS 40

12. THE UNITED STATES 47

Cardiovascular Diseases in the US: A Review 47

30% Fall in Number of Deaths due to Heart Diseases & Strokes

Over Last Decade 47

Senior Citizens at High Risk for Heart Failure 48

CHF Biomarkers to Spearhead the US market 48

US Cardiac Markers POCT Segment 48

13. EUROPE 52

a. France 57

b. Germany 58

c. Italy 59

d. The United Kingdom 60

e. Rest of Europe 62

14. REST OF WORLD 63

Evolution of BNP Test market in Japan 63

Table 1: Region-Wise Incidence and Prevalence of

Cardiovascular Diseases in 2006

EXHIBITS

Table 2: Global Cardiac Biomarkers Market by Region for the

Period 2007-2015 (Sales in US$ Million)

Table 3: Percentage Breakdown of Global Cardiac Biomarkers

Market by Region for the Years 2009 & 2012

Table 4: Global Cardiac Biomarkers Market in Laboratory

Testing Sector by Region for the Period 2007-2015 (Sales in

US$ Million)

Table 5: Percentage Breakdown of Global Cardiac Biomarkers

Market in Laboratory Testing Sector by Region for the Years

2009 & 2012

Table 6: Global Cardiac Biomarkers Market in Point-of-Care

Testing Sector by Region for the Period 2007-2015 (Sales in

US$ Million)

Table 7: Percentage Breakdown of Global Cardiac Biomarkers

Market in Point-of-Care Testing Sector by Region for the Years

2009 & 2012

Table 8: Global CK-MB Assay Test Market by Region for the

Period 2007-2015 (Sales in US$ Million)

Table 9: Percentage Breakdown of Global CK-MB Assay Test

Market by Region for the Years 2009 & 2012

Table 10: Global Cardiac Troponin Assay Test Market by Region

for the Period 2007-2015 (Sales in US$ Million)

Table 11: Percentage Breakdown of Global Cardiac Troponin

Assay Test Market by Region for the Years 2009 & 2012

Table 12: Global Myoglobin Assay Test Market by Region for the

Period 2007-2015 (Sales in US$ Million)

Table 13: Percentage Breakdown of Global Myoglobin Assay Test

Market by Region for the Years 2009 & 2012

Table 14: Global BNP & NT pro-BNP Assay Test Market by Region

for the Period 2007-2015 (Sales in US$ Million)

Table 15: Percentage Breakdown of Global BNP & NT pro-BNP

Assay Test Market by Region for the Years 2009 & 2012

Table 16: Market Shares of Leading AMI (Acute Myocardial

Infarction) Diagnostics Manufacturer Revenues in the US - 2006

Table 17: Market Shares of Leading CHF (Congestive Heart

Failure) Diagnostics Manufacturer Revenues in the US - 2006

Table 18: Market Shares of Leading Manufacturers in the

Laboratory Testing Segment in the US - 2001

Table 19: Cardiac Biomarkers Market by Segment in the US:

2007-2015 (Sales in US$ Million)

Table 20: Percentage Breakdown of Cardiac Biomarkers Market by

Segment in the US for the Years 2009 & 2012

Table 21: Cardiac Biomarkers Market by Test Type in the US:

2007-2015 (Sales in US$ Million)

Table 22: Percentage Breakdown of Cardiac Biomarkers Market by

Test Type in the US for the Years 2009 & 2012

Table 23: Cardiac Biomarkers Market by Region in Europe:

2007-2015 (Sales in US$ Million)

Table 24: Percentage Breakdown of Cardiac Biomarkers Market by

Region in Europe for the Years 2009 & 2012

Table 25: Cardiac Biomarkers Market by Segment in Europe:

2007-2015 (Sales in US$ Million)

Table 26: Percentage Breakdown of Cardiac Biomarkers Market by

Segment in Europe for the Years 2009 & 2012

Table 27: Cardiac Biomarkers Market by Assay Test Type in

Europe: 2007-2015 (Sales in US$ Million)

Table 28: Percentage Breakdown of Cardiac Biomarkers Market by

Assay Test Type in Europe for the Years 2009 & 2012

Table 29: Cardiac Biomarkers Market by Segment in France:

2007-2015 (Sales in US$ Million)

Table 30: Percentage Breakdown of Cardiac Biomarkers Market by

Segment in France for the Years 2009 & 2012

Table 31: Cardiac Biomarkers Market by Segment in Germany:

2007-2015 (Sales in US$ Million)

Table 32: Percentage Breakdown of Cardiac Biomarkers Market by

Segment in Germany for the Years 2009 & 2012

Table 33: Cardiac Biomarkers Market by Segment in Italy:

2007-2015 (Sales in US$ Million)

Table 34: Percentage Breakdown of Cardiac Biomarkers Market by

Segment in Italy for the Years 2009 & 2012

Table 35: Cardiac Biomarkers Market by Segment in the UK:

2007-2015 (Sales in US$ Million)

Table 36: Percentage Breakdown of Cardiac Biomarkers Market by

Segment in the UK for the Years 2009 & 2012

Table 37: Cardiac Biomarkers Market by Segment in Rest of

Europe: 2007-2015 (Sales in US$ Million)

Table 38: Percentage Breakdown of Cardiac Biomarkers Market by

Segment in Rest of Europe for the Years 2009 & 2012

Table 39: Cardiac Biomarkers Market by Segment in Rest of

World: 2007-2015 (Sales in US$ Million)

Table 40: Percentage Breakdown of Cardiac Biomarkers Market by

Segment in Rest of World for the Years 2009 & 2012

Table 41: Cardiac Biomarkers Market by Assay Test Type in Rest

of World: 2007-2015 (Sales in US$ Million)

Table 42: Percentage Breakdown of Cardiac Biomarkers Market by

Assay Test Type in Rest of World for the Years 2009 & 2012

COMPANIES PROFILED

To order this report:

Cardiovascular Devices Industry: Cardiac Biomarkers - A Global Market Perspective

More Market Research Report


Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker


'/>"/>
SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis
2. Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review
3. Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review
4. Reportlinker Adds Radiation Therapy Equipment - A Global Market Review
5. Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities
6. Reportlinker Adds Training Manikins - Global Trends
7. Reportlinker Adds Immunoassay Instruments - Global Market Trends
8. Reportlinker Adds Hospital Information Systems - A Global Update of Market Trends & Opportunities
9. Reportlinker Adds Arthroscopes - A World Market Review
10. Reportlinker Adds Cardiac Pacemakers - A World Market Analysis
11. Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... 27, 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ... whatever measures required to build a strong and stable ... currently listed on the OTC Markets-pink current trading platform. ... CEO, "We are seeing an anomaly in market trading ... only by the Company, but shareholders and market players ...
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, ... design, development and manufacturing of collagen and mineral ... announced today that Bill Messer has ... Marketing to further leverage the growing portfolio of ... devices. Bill joins the Collagen Matrix ...
(Date:6/24/2016)... 24, 2016 ... the addition of the " Global Markets for ... This report focuses on ... updated review, including its applications in various applications. The ... which includes three main industries: pharmaceutical and biotechnology, food ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... payment industry today announced its strategic partnership with Connance, a healthcare industry ... The two companies’ proven, proprietary technology combine to provide health systems, hospitals ...
(Date:6/26/2016)... ... 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect ... videos a whole new perspective by using the title layers in ProSlice Levels ... , ProSlice Levels contains over 30 Different presets to choose from. FCPX ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Austin residents ... the American College of Mohs Surgery and to Dr. Russell Peckham for medical and ... highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
Breaking Medicine News(10 mins):